AI assistant for cancer diagnosis: will it help doctors spot tumors better?

NCT ID NCT07291362

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Nanfang Hospital, Southern Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an artificial intelligence (AI) model can help pathologists diagnose gastric cancer more accurately and quickly. About 1000 patients with gastric biopsies or surgical samples will take part. Some pathologists will use the AI tool to assist their diagnosis, while others will work as usual. The goal is to see if AI improves accuracy, speed, and confidence, especially for less experienced pathologists.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI pathology model
What this could lead to: If successful, this could show that AI helps pathologists diagnose gastric cancer faster and more accurately, especially for less experienced doctors.
What could go wrong: This is a diagnostic study, not a treatment trial. The AI may not improve accuracy for all pathologists, and results may not apply to other cancers or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERDISCIPLINARY RESEARCH PATHOLOGY FOUNDATION MODEL RANDOMIZED CONTROLLED TRIAL

Contacts and locations

Locations

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, 510515, China
The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.